Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Oligo-Astrocytoma”

7 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 7 of 7 results

Testing effectiveness (Phase 2)UnknownNCT00114309
What this trial is testing

131-I-TM-601 Study in Adults With Recurrent High-Grade Glioma

Who this might be right for
Malignant GliomaGlioblastoma MultiformeGBM+3 more
TransMolecular 66
Early research (Phase 1)Study completedNCT00526812
What this trial is testing

A Safety Study of RTA 744 in Patients With Recurrent High-Grade Gliomas

Who this might be right for
Glioma
Biogen 54
Testing effectiveness (Phase 2)Ended earlyNCT01986348
What this trial is testing

Study Evaluating the Efficacy and Safety of Selinexor (KPT-330) in Participants With Recurrent Gliomas

Who this might be right for
GlioblastomaGlioma
Karyopharm Therapeutics Inc 76
Early research (Phase 1)Study completedNCT01392209
What this trial is testing

Hypofractionated Stereotactic Radiotherapy With Bevacizumab in the Treatment of Recurrent Malignant Glioma

Who this might be right for
Brain CancerMALIGNANT GLIOMAGlioblastoma+5 more
Memorial Sloan Kettering Cancer Center 15
Not applicableStudy completedNCT00876499
What this trial is testing

Fatigue, Sleep and Cytokines in Primary Brain Tumor (PBT) Patients

Who this might be right for
Brain Cancer
M.D. Anderson Cancer Center 20
Early research (Phase 1)Active Not RecruitingNCT03152318
What this trial is testing

The Treatment of Recurrent Malignant Glioma With rQNestin34.5v.2

Who this might be right for
Malignant Glioma of BrainAstrocytomaMalignant Astrocytoma+11 more
Dana-Farber Cancer Institute 62
Very early researchStudy completedNCT00795457
What this trial is testing

Effects of Vaccinations With HLA-A2-Restricted Glioma Antigen-Peptides in Combination With Poly-ICLC for Adults With High-Risk WHO Grade II Astrocytomas and Oligo-Astrocytomas

Who this might be right for
AstrocytomaOligo-AstrocytomaGlioma
Ian F. Pollack, M.D. 13